Age is a key factor. Despite Wegovy receiving FDA approval for children ages 12 and up, only 0.2% of Americans under 18 with ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Despite policies that have been created with the goal of limiting kids’ sugar intake via sweetened drinks, a new study conducted by researchers from the UConn Rudd Center for Food Policy and Obesity ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Researchers in Lebanon, who tracked more than 200 obese adults in their 70s, found the vitamin lowered blood pressure levels ...
Adopting a healthy diet and engaging in regular physical activity are essential for preventing weight gain. Small steps can ...
Age is a key factor. Despite Wegovy receiving FDA approval for children ages 12 and up, only 0.2% of Americans under 18 with ...
Age is a key factor. Despite Wegovy receiving FDA approval for children ages 12 and up, only 0.2% of Americans under 18 with ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback